| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | SVP, Finance &CAO | SVP, Finance &CAO +1 more
1 company
Utter Christine Marie is a SVP, Chief Accounting Officer at PTC THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell | 1,034 | $76.45 | $79,049.30 | -1.4% | -7.3% | - | |
| Jan 7, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell | 2,616 | $77.19 | $201,918.70 | -1.7% | -9.9% | - | |
| Feb 20, 2025 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell | 1,757 | $50.11 | $88,043.26 | -1.4% | -8.3% | +40.3% | |
| Jan 8, 2025 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell | 2,953 | $44.87 | $132,492.94 | -2.2% | -11.7% | +70.6% | |
| Dec 2, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sale+OE | 17,800 | $51.77 | $921,585.17 | -7.6% | +1.5% | +50.7% | |
| Jan 30, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell | 318 | $27.25 | $8,665.75 | -0.9% | +21.0% | +70.3% | |
| Jan 9, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell | 2,841 | $28.86 | $81,986.14 | -3.7% | -6.4% | +56.9% | |
| Apr 21, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 4,692 | $55.06 | $258,325.90 | -3.9% | -29.0% | -54.1% | |
| Mar 29, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 4,688 | $47.79 | $224,044.17 | -5.7% | -14.7% | -39.6% | |
| Mar 27, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE | 26,658 | $45.09 | $1,202,105.75 | -9.9% | -11.7% | -38.9% |